PC14586
PMV-586-101
Phase 2 small_molecule active
Quick answer
PC14586 for Locally Advanced or Metastatic Solid Tumors Harboring a TP53 Y220C Mutation is a Phase 2 program (small_molecule) at PMV Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PMV Pharmaceuticals
- Indication
- Locally Advanced or Metastatic Solid Tumors Harboring a TP53 Y220C Mutation
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active